P1185: antitumor activity and safety of zanubrutinib combined with r-chop regimen in the treatment of newly diagnosed non-gcb dlbcl with extranodal involvement: a prospective phase ii study.
HemaSphere（2022）
关键词
zanubrutinib combined,antitumor activity,r-chop,non-gcb
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要